Syndax Pharmaceuticals (SNDX) saw its stock price drop sharply by 5.20% during Tuesday's intraday trading session. The decline comes as analysts expressed conflicting sentiments about the company's prospects in a recent report.
The healthcare sector has been under scrutiny, with analysts weighing in on various companies, including Syndax Pharmaceuticals. The mixed opinions from analysts may have contributed to investor uncertainty, leading to the significant sell-off observed in SNDX shares.